

ARDS Part II
Aug 11, 2023
Topics discussed include ESICM guidelines and definition of ARDS, phenotypes and respiratory support, corticosteroids, NMBA and VV ECMO, prone positioning in ARDS, absence of corticosteroids in guidelines, and personalized treatment strategies based on sub-phenotypes and biomarker profiles.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Introduction
00:00 • 2min
Recent Guidelines on ARDS: Evaluating Evidence and Limitations
02:29 • 9min
Understanding ARDS Phenotypes and Sub-Phenotypes
11:36 • 9min
Possibility of Ordering Biomarker Levels and Lung Protective Ventilation Strategy in ARDS
20:26 • 2min
Prone Positioning in ARDS and the Role of Self-Proning in COVID-19
22:13 • 2min
The Absence of Corticosteroids in ARDS Guidelines
23:48 • 20min
Guidelines and Recommendations for ARDS Treatment
43:31 • 6min
Acknowledgements, Feedback, and Sponsors
49:30 • 2min